Goodman Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Hold |
1,680
| – | – | 0.04% | 67 |
|
|
2025
Q1 | $122K | Buy |
+1,680
| New | +$122K | 0.04% | 85 |
|
|
2024
Q4 | – | Sell |
-1,680
| Closed | -$111K | – | 90 |
|
|
2024
Q3 | $111K | Hold |
1,680
| – | – | 0.03% | 97 |
|
|
2024
Q2 | $155K | Hold |
1,680
| – | – | 0.05% | 89 |
|
|
2024
Q1 | $161K | Hold |
1,680
| – | – | 0.05% | 75 |
|
|
2023
Q4 | $128K | Hold |
1,680
| – | – | 0.04% | 74 |
|
|
2023
Q3 | $116K | Hold |
1,680
| – | – | 0.04% | 80 |
|
|
2023
Q2 | $158K | Hold |
1,680
| – | – | 0.06% | 64 |
|
|
2023
Q1 | $139K | Hold |
1,680
| – | – | 0.08% | 58 |
|
|
2022
Q4 | $125K | Hold |
1,680
| – | – | 0.07% | 58 |
|
|
2022
Q3 | $139K | Hold |
1,680
| – | – | 0.08% | 56 |
|
|
2022
Q2 | $160K | Buy |
+1,680
| New | +$160K | 0.07% | 52 |
|